scholarly article | Q13442814 |
P50 | author | Julian Carretero | Q42890318 |
Javier Pereda | Q56241139 | ||
Gaetano Serviddio | Q57339752 | ||
Jose Vina | Q72143204 | ||
P2093 | author name string | Juan Sastre | |
Giuseppe Poli | |||
Federico V Pallardó | |||
Gianluigi Vendemiale | |||
Consuelo Borras | |||
Juan Cutrin | |||
P2860 | cites work | A multicenter, controlled trial of ursodiol for the treatment of primary biliary cirrhosis. UDCA-PBC Study Group | Q28243457 |
Ursodeoxycholic acid protects hepatocytes against oxidative injury via induction of antioxidants | Q28373006 | ||
Ursodeoxycholic acid may inhibit deoxycholic acid-induced apoptosis by modulating mitochondrial transmembrane potential and reactive oxygen species production | Q28379482 | ||
Bile acid-induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition | Q32075959 | ||
Primary biliary cirrhosis: an orchestrated immune response against epithelial cells | Q33916633 | ||
Studies on the regulation of glutathione level in rat liver | Q34203084 | ||
Hormone-mediated down-regulation of hepatic glutathione synthesis in the rat | Q34225743 | ||
Ursodeoxycholic acid 'mechanisms of action and clinical use in hepatobiliary disorders'. | Q34330984 | ||
A novel role for ursodeoxycholic acid in inhibiting apoptosis by modulating mitochondrial membrane perturbation | Q37383640 | ||
Oxidative stress, thiol reagents, and membrane potential modulate the mitochondrial permeability transition by affecting nucleotide binding to the adenine nucleotide translocase | Q38559578 | ||
Reaction of formiminoglutamate with liver glutamate dehydrogenase | Q40144427 | ||
The effect of ursodeoxycholic acid therapy on liver fibrosis progression in primary biliary cirrhosis | Q40737262 | ||
Combined analysis of randomized controlled trials of ursodeoxycholic acid in primary biliary cirrhosis | Q40883127 | ||
Inhibition of apoptosis by antioxidants in the human HL-60 leukemia cell line | Q41293446 | ||
Generation of hydroperoxides in isolated rat hepatocytes and hepatic mitochondria exposed to hydrophobic bile acids | Q41668171 | ||
Reactive oxygen species affect mitochondrial electron transport complex I activity through oxidative cardiolipin damage | Q42519929 | ||
Interferon/antioxidant combination therapy for chronic hepatitis C--a controlled pilot trial | Q42995489 | ||
Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats | Q43006361 | ||
Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver | Q43601206 | ||
Inhibition of the MAPK and PI3K pathways enhances UDCA-induced apoptosis in primary rodent hepatocytes | Q43933924 | ||
Mitochondrial oxidative stress and CD95 ligand: a dual mechanism for hepatocyte apoptosis in chronic alcoholism. | Q43974839 | ||
Antioxidant defenses in the bile duct-ligated rat | Q46424638 | ||
Oxidative stress induces apoptosis in embryonic cortical neurons. | Q48226359 | ||
Ursodeoxycholate reduces hepatotoxicity of bile salts in primary human hepatocytes. | Q50878460 | ||
Analysis of the membrane potential of rat- and mouse-liver mitochondria by flow cytometry and possible applications. | Q54085818 | ||
10-N nonyl-acridine orange: a fluorescent probe which stains mitochondria independently of their energetic state. | Q54491447 | ||
Reduced mRNA abundance of the main enzymes involved in methionine metabolism in human liver cirrhosis and hepatocellular carcinoma | Q62727088 | ||
Molecular aspects of membrane stabilization by ursodeoxycholate [see comment] | Q70457384 | ||
Modulation of matrix Ca2+ content by the ADP/ATP carrier in brown adipose tissue mitochondria. Influence of membrane lipid composition | Q71483200 | ||
Primary biliary cirrhosis | Q71742524 | ||
A fast kinetic method for assessing mitochondrial membrane potential in isolated hepatocytes with rhodamine 123 and flow cytometry | Q72048392 | ||
Protective effect of S-adenosyl-l-methionine on liver damage induced by biliary obstruction in rats: a histological, ultrastructural and biochemical approach | Q72812628 | ||
Vitamin E reduces oxidant injury to mitochondria and the hepatotoxicity of taurochenodeoxycholic acid in the rat | Q74036220 | ||
Evidence for accelerated generation of hydroxyl radicals in experimental obstructive jaundice of rats | Q74545781 | ||
Cholestasis confers resistance to the rat liver mitochondrial permeability transition | Q77164927 | ||
Effect of oxypurinol, a xanthine oxidase inhibitor, on hepatic injury in the bile duct-ligated rat | Q77199438 | ||
Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis: studies in vivo and in vitro | Q77774290 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P1104 | number of pages | 10 | |
P304 | page(s) | 711-720 | |
P577 | publication date | 2004-03-01 | |
P1433 | published in | Hepatology | Q15724398 |
P1476 | title | Ursodeoxycholic acid protects against secondary biliary cirrhosis in rats by preventing mitochondrial oxidative stress | |
P478 | volume | 39 |
Q36172470 | A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease |
Q36116022 | Advances in pharmacotherapy for primary biliary cirrhosis |
Q46703575 | Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model |
Q37157813 | Bile-acid-induced cell injury and protection |
Q41095627 | Chemical chaperone, TUDCA unlike PBA, mitigates protein aggregation efficiently and resists ER and non-ER stress induced HepG2 cell death |
Q47145626 | Curcumin enhances liver SIRT3 expression in the rat model of cirrhosis. |
Q34634218 | Decreasing mitochondrial fission prevents cholestatic liver injury |
Q42099362 | Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications |
Q33213710 | Effects of total glucosides of peony on immunological hepatic fibrosis in rats |
Q79537490 | Erdosteine treatment attenuates oxidative stress and fibrosis in experimental biliary obstruction |
Q41823793 | Hepatic fibrosis in biliary-obstructed rats is prevented by Ginkgo biloba treatment |
Q53622503 | Is ursodeoxycholic acid crucial for ischemia/reperfusion-induced ovarian injury in rat ovary? |
Q35010560 | Liver fibrosis caused by choledocholith to regress after biliary drainage |
Q53122729 | Liver-specific p38α deficiency causes reduced cell growth and cytokinesis failure during chronic biliary cirrhosis in mice. |
Q46005599 | Many faces of mitochondrial uncoupling during age: damage or defense? |
Q37158649 | Melatonin ameliorates experimental hepatic fibrosis induced by carbon tetrachloride in rats |
Q53137606 | Melatonin attenuates oxidative stress, liver damage and hepatocyte apoptosis after bile-duct ligation in rats. |
Q37815476 | Mitochondria and redox signaling in steatohepatitis |
Q37863137 | Mitochondrial dysfunction in nonalcoholic steatohepatitis |
Q35730907 | Oral solubilized ursodeoxycholic acid therapy in amyotrophic lateral sclerosis: a randomized cross-over trial |
Q85057882 | Overexpression of Bcl-2 in hepatocytes protects against injury but does not attenuate fibrosis in a mouse model of chronic cholestatic liver disease |
Q87561627 | Oxidative stress and antioxidant status in patients with autoimmune liver diseases |
Q42726334 | Pathogenesis of primary biliary cirrhosis: a unifying model |
Q33626823 | Pathogenic role of oxidative and nitrosative stress in primary biliary cirrhosis |
Q36316956 | Pathophysiological basis for antioxidant therapy in chronic liver disease |
Q26799419 | Primary biliary cirrhosis: From bench to bedside |
Q37413654 | Protection against hepatocyte mitochondrial dysfunction delays fibrosis progression in mice |
Q44814235 | Protective effect of Urtica dioica on liver damage induced by biliary obstruction in rats |
Q42853765 | Protective effect of quercetin on liver damage induced by biliary obstruction in rats |
Q46955366 | Protective effect of the roots extract of Platycodon grandiflorum on bile duct ligation-induced hepatic fibrosis in rats. |
Q53190285 | Protective effects of thymoquinone against cholestatic oxidative stress and hepatic damage after biliary obstruction in rats. |
Q24655260 | Regulation of glutathione synthesis |
Q89895213 | Running Head: Heat Affects Cholesterol and Bile Acid Alterations in Cholesterol and Bile Acids Metabolism in Large White Pigs during Short-Term Heat Exposure |
Q39104518 | Silymarin/Silybin and Chronic Liver Disease: A Marriage of Many Years. |
Q47103439 | Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression. |
Q44671188 | The efficiency of CAPE on retardation of hepatic fibrosis in biliary obstructed rats |
Q46656767 | The third gas: H2S regulates perfusion pressure in both the isolated and perfused normal rat liver and in cirrhosis |
Q37777155 | Update on the pathophysiology of liver fibrosis |
Q39677430 | Ursodeoxycholic acid and superoxide anion |
Q37919924 | Ursodeoxycholic acid in cholestasis: linking action mechanisms to therapeutic applications. |
Q34139873 | Ursodeoxycholic acid prevents selenite-induced oxidative stress and alleviates cataract formation: In vitro and in vivo studies. |
Q46440176 | Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice |
Q51373827 | Ursodeoxycholic acid treatment of hepatic steatosis: a (13)C NMR metabolic study. |
Q83868802 | [Liver apoptosis] |
Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120 Warning: Trying to access array offset on value of type null in /home/httpd/vhosts/renenyffenegger.ch/opendata.renenyffenegger.ch/Wikimedia/Wikidata/entity/main.php on line 1120
Search more.